Phase
Condition
Brain Injury
Covid-19
Treatment
percutaneous electrical nerve-field stimulation, PENFS
percutaneous electrical nerve-field stimulation, PENFS (COVID active device)
percutaneous electrical nerve-field stimulation, PENFS (sham device)
Clinical Study ID
Ages 11-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Concussion:
Inclusion Criteria:
Clinical diagnosis of Post-Concussion Syndrome
Post-Concussion Symptoms for at least 3 months along with lack of other explanationfor their symptoms
English and Spanish-speaking families
Exclusion
Exclusion Criteria:
Seizure disorders
Significant developmental delay
Infection or severe dermatological condition of ear
Bleeding disorders
Implanted electrical device
COVID:
Inclusion Criteria
Child is in between the ages 11-18
Child is present at CHOC Neurology clinic post covid-19 symptoms of more than 3months duration along with lack of other explanation for their symptoms
English-speaking and Spanish-speaking families
You cannot participate in this study if you meet the following exclusion criteria:
Children with significant developmental delay, infection or severe dermatologicalcondition of ear, bleeding disorders, or having any implanted electrical device willbe excluded.
Are not able to attend Friday appointments for the Neurostim placements.
Study Design
Study Description
Connect with a study center
CHOC Children's
Orange, California 92868
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.